Beatriz De Paiva Mendes

Ms. Beatriz De Paiva Mendes

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in RECIMA21 - Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
BMBeatriz De Paiva Mendes
Beatriz De Paiva Mendes
JSJenifer Inocencio Silva
Jenifer Inocencio Silva
LFLorrana Fonseca
Lorrana Fonseca
Os patógenos “ESKAPE” – Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa e Enterobacter spp. – causam infecções nosocomiais e estão estritamente associadas à crescente resistência antimicrobiana (RAM). O uso indiscriminado de antibióticos tem intensificado esse cenário, comprometendo a eficácia dos tratamentos convencionais e exigindo novas estratégias terapêuticas. Nesse contexto, os bacteriófagos – vírus que infectam e destroem bactérias – destacam-se como alternativas promissoras. Este artigo investiga o potencial da fagoterapia contra essas seis espécies multirresistentes através da análise de estudos publicados entre 2015-2025 nos repositórios PubMed, SciELO e Google Scholar. Consideraram-se trabalhos nos idiomas inglês e português e com enfoque em aplicações terapêuticas. Os resultados apontaram que a RAM nessas bactérias ocorre a partir da produção de enzimas inativadoras, mutações em alvos antibióticos, alteração da permeabilidade de membrana e formação de biofilmes. Os fagos demonstraram alta especificidade, replicação eficiente e baixa toxicidade, atuando seletivamente sobre as bactérias patogênicas. Evidências experimentais e clínicas reforçam sua eficácia, especialmente quando antibióticos falham, e sugerem efeitos sinérgicos com essas drogas. A fagoterapia ressurge, portanto, como uma abordagem personalizada e promissora para o tratamento de infecções associadas à assistência à saúde.

Verified
Conference Paper
Open access
PDF file
VPVictor hugo Gonçalves Pinto
Victor hugo Gonçalves Pinto
SSSamuel Dias da Silva
Samuel Dias da Silva
BMBeatriz De Paiva Mendes
Beatriz De Paiva Mendes
VDVictor Hugo Giordano Dias
Victor Hugo Giordano Dias
MRMarcos Dornelas Ribeiro
Marcos Dornelas Ribeiro
VAVirginia Sara Grancieri do Amaral
Virginia Sara Grancieri do Amaral
Bacterial toxins, such as Staphylococcal Enterotoxin B (SEB) and Shiga Toxins (STX1, STX2), pose severe public health risks and significant biological threats, demanding rapid and precise qPCR detection. This study reports the initial stages of standardization for uniplex qPCR components, serving as a foundational step toward a future multiplex detection system. The annealing temperature was successfully optimized for the stx1, seb, and 16S rRNA targets, showing high consistency in Cq values and fluorescence intensities at 58.4 °C. The optimized primer ratios ensure maximum amplification efficiency while minimizing potential molecular competition. These optimized assays provide a robust foundation for the multiplex qPCR platform. Once fully validated, this protocol will enhance timely and effective responses, as well as improve preparedness and readiness within the Brazilian biodefense system.

18 November 2025 in Biology and Life Sciences Forum
Verified
Conference Paper
Open access
PDF file
VSVanessa dos Santos Silva
Vanessa dos Santos Silva
BMBeatriz De Paiva Mendes
Beatriz De Paiva Mendes
DLDaniel Vinícius Neves De Lima
Daniel Vinícius Neves De Lima
TNTatiana Nogueira
Tatiana Nogueira
VAVirginia do Amaral
Virginia do Amaral
Historically, saxitoxin (STX) and its analogs, like neosaxitoxin (NeoSTX), have been restricted to scientific research due to their potent toxicity, despite their potential as therapeutic agents. This study aimed to evaluate the pharmacological versatility of STX and NeoSTX through molecular docking. Using the SwissTargetPrediction server, 18 potential human therapeutic targets were identified, with the 5-HT6 receptor being the primary target. Molecular docking assays were performed with AutoDock Vina version 1.1.2, and the lowest-energy pose for NeoSTX (−5.7 kcal/mol) suggested a stronger binding affinity compared to STX (−5.5 kcal/mol). The analysis of the binding mode revealed key interactions, including hydrogen bonds with Thr199 and hydrophobic contacts with Phe285. These findings provide robust hypotheses regarding the therapeutic potential of NeoSTX as a 5-HT6 receptor antagonist, supporting the development of novel bioactive agents derived from these marine toxins.